Orbimed Advisors LLC Compass Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 22,362,850 shares of CMPX stock, worth $65.3 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
22,362,850
Previous 22,362,850
-0.0%
Holding current value
$65.3 Million
Previous $41.1 Million
21.19%
% of portfolio
0.88%
Previous 0.97%
Shares
3 transactions
Others Institutions Holding CMPX
# of Institutions
89Shares Held
93.2MCall Options Held
0Put Options Held
0-
Blackstone Inc New York, NY10MShares$29.3 Million0.07% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.57MShares$25 Million1.86% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$19.3 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.99MShares$17.5 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA5.9MShares$17.2 Million0.64% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $296M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...